Skip to main content

Rafferty Asset Management, LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1389426 New York, NY

Position in AKBA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$454,682
-$348,101 QoQ
Shares Held
327,110
-34.4% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Rafferty Asset Management, LLC holds $27,250,101 across 15 Drug Manufacturers - Specialty & Generic names. AKBA ranks #9 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AKBA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $454,682 327,110
2025-12-31 $802,783 498,623
2025-09-30 $1,315,502 481,869
2025-06-30 $924,392 253,954
2025-03-31 $396,729 206,630
2024-12-31 $341,528 179,752
2022-03-31 $504,500 702,647
2021-12-31 $1,668,049 738,075
2021-09-30 $1,940,944 673,939
2021-06-30 $2,254,845 594,946
2021-03-31 $3,124,199 922,954
2020-12-31 $823,281 294,029
2020-09-30 $1,290,732 514,236
2020-06-30 $582,228 42,874